Charlotte's Web Holdings (CWBHF) Cash from Investing Activities (2021 - 2026)

Charlotte's Web Holdings' (CWBHF) quarterly Cash from Investing Activities came in at -$17000.0 in Q1 2026, up 96.55% year-on-year from -$8649.1 in Q1 2025, and down 114.66% on a QoQ basis from $116000.0 in Q4 2025.

Charlotte's Web Holdings (CWBHF) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Charlotte's Web Holdings (CWBHF) has 6 years of Cash from Investing Activities data on file, last reported at -$17000.0 in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 96.55% year-over-year to -$17000.0 in Q1 2026; TTM through Mar 2026 was $64000.0, a 102.84% increase from a year earlier, with the FY2025 full-year figure at -$412000.0, up 89.15% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$17000.0, down from $116000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for CWBHF reached as high as $452000.0 in Q4 2022 and fell as low as -$2.7 million in Q3 2023.
  • Historically, Cash from Investing Activities has averaged -$431529.4 across 5 years, with a median of -$111000.0 in 2023.
  • Across the five-year window, Cash from Investing Activities surged 164.66% in 2022 and sank 4982.5% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at $452000.0 in 2022, then slumped by 234.96% to -$610000.0 in 2023, then surged by 67.54% to -$198000.0 in 2024, then jumped by 158.59% to $116000.0 in 2025, then plunged by 114.66% to -$17000.0 in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$17000.0 in Q1 2026, $116000.0 in Q4 2025, and $11000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -60.00 Mn
10 Charlotte's Web Holdings 41.51 Mn 36.32 Mn 5.20 Mn -17,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -17,000.00
Mar 31, 2026 -17,000.00
Dec 31, 2025 116,000.00
Dec 31, 2025 116,000.00
Sep 30, 2025 11,000.00
Sep 30, 2025 11,000.00
Jun 30, 2025 -46,000.00
Jun 30, 2025 -46,000.00
Mar 31, 2025 -493,000.00
Mar 31, 2025 -493,000.00
Dec 31, 2024 -198,000.00
Dec 31, 2024 -198,000.00
Sep 30, 2024 -310,000.00
Sep 30, 2024 -310,000.00
Jun 30, 2024 -1.26 Mn
Jun 30, 2024 -1.26 Mn
Mar 31, 2024 -2.03 Mn
Mar 31, 2024 -2.03 Mn
Dec 31, 2023 -610,000.00
Dec 31, 2023 -610,000.00